Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaki Iida is active.

Publication


Featured researches published by Masaki Iida.


Radiotherapy and Oncology | 2014

Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases

Kenji Mitsudo; Toshiyuki Koizumi; Masaki Iida; Toshinori Iwai; Hideyuki Nakashima; Senri Oguri; Mitomu Kioi; Makoto Hirota; Izumi Koike; Masaharu Hata; Iwai Tohnai

PURPOSE To evaluate the therapeutic results and rate of organ preservation in patients with stage III or IV oral cancer treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy. MATERIALS AND METHODS One hundred and twelve patients with stage III and IV oral squamous cell carcinoma underwent intra-arterial chemoradiotherapy. Catheterization from the superficial temporal and occipital arteries was performed. Treatment consisted of superselective intra-arterial chemotherapy (docetaxel, total 60mg/m(2), cisplatin, total 150mg/m(2)) and daily concurrent radiotherapy (total of 60Gy) for 6 weeks. RESULTS The median follow-up for all patients was 46.2 months (range, 10-76 months). After intra-arterial chemoradiotherapy, primary site complete response was achieved in 98 (87.5%) of 112 cases. Five-year survival and local control rates were 71.3% and 79.3%, respectively. Grade 3 or 4 toxicities included mucositis in 92.0%, neutropenia in 30.4%, dermatitis in 28.6%, anemia in 26.8%, and thrombocytopenia in 7.1% of patients. Grade 3 toxicities included dysphagia in 72.3%, nausea/vomiting in 21.4%, fever in 8.0%, and renal failure in 0.9% of patients. CONCLUSION Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer provided good overall survival and local control.


International Journal of Radiation Oncology Biology Physics | 2012

Thermochemoradiation Therapy Using Superselective Intra-arterial Infusion via Superficial Temporal and Occipital Arteries for Oral Cancer With N3 Cervical Lymph Node Metastases

Kenji Mitsudo; Toshiyuki Koizumi; Masaki Iida; Toshinori Iwai; Senri Oguri; Noriyuki Yamamoto; Yoshiyuki Itoh; Mitomu Kioi; Makoto Hirota; Iwai Tohnai

PURPOSE To evaluate the therapeutic results and histopathological effects of treatment with thermochemoradiation therapy using superselective intra-arterial infusion via the superficial temporal and occipital arteries for N3 cervical lymph node metastases of advanced oral cancer. METHODS AND MATERIALS Between April 2005 and September 2010, 9 patients with N3 cervical lymph node metastases of oral squamous cell carcinoma underwent thermochemoradiation therapy using superselective intra-arterial infusion with docetaxel (DOC) and cisplatin (CDDP). Treatment consisted of hyperthermia (2-8 sessions), superselective intra-arterial infusions (DOC, total 40-60 mg/m(2); CDDP, total 100-150 mg/m(2)) and daily concurrent radiation therapy (total, 40-60 Gy) for 4-6 weeks. RESULTS Six of 9 patients underwent neck dissection 5-8 weeks after treatment. In four of these 6 patients, all metastatic lymph nodes, including those at N3, were grade 3 (non-viable tumor cells present) or grade 4 (no tumor cells present) tumors, as classified by the system by Shimosato et al (Shimosato et al Jpn J Clin Oncol 1971;1:19-35). In 2 of these 6 patients, the metastatic lymph nodes were grade 2b (destruction of tumor structures with a small amount of residual viable tumor cells). The other 3 patients did not undergo neck dissection due to distant metastasis after completion of thermochemoradiation therapy (n=2) and refusal (n=1). The patient who refused neck dissection underwent biopsy of the N3 lymph node and primary sites and showed grade 3 cancer. During follow-up, 5 patients were alive without disease, and 4 patients died due to pulmonary metastasis (n=3) and noncancer-related causes (n=1). Five-year survival and locoregional control rates were 51% and 88%, respectively. CONCLUSIONS Thermochemoradiation therapy using intra-arterial infusion provided good histopathologic effects and locoregional control rates in patients with N3 metastatic lymph nodes. However, patients with N3 metastatic lymph nodes experienced a high rate of distant metastases.


The Open Dentistry Journal | 2015

Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients

Kosuke Naganawa; Eiji Takayama; Makoto Adachi; Kenji Mitsudo; Masaki Iida; Masako Kamiya-Mizuno; Harumi Kawaki; Masao Ichinose; Masayuki Motohashi; Yasunori Muramatsu; Iwai Tohnai; Shinichiro Sumitomo; Michio Shikimori; Nobuo Kondoh

In order to evaluate the Th1 and Th2 responses of Oral Squamous Cell Carcinoma (OSCC) patients, we investigated the cytokine producing capability of peripheral blood (PB), and compared it with clinicopathological appearances of OSCC patients. The production of a Th1-type cytokine, interferon (IFN)-γ, from lipopolysaccharide (LPS)-stimulated PB correlated positively with the frequency of lymph node metastasis. We also investigated the production of a Th2-type cytokine, IL-10, however, no significant correlation was observed with the clinicopathological appearances. Our results suggested that the IFN-γ producing capability was specifically regulated and dependent on the regional metastatic potencies of OSCCs.


Oral Oncology | 2018

Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases

Kenji Mitsudo; Yuichiro Hayashi; Shuhei Minamiyama; Nobuhide Ohashi; Masaki Iida; Toshinori Iwai; Senri Oguri; Toshiyuki Koizumi; Mitomu Kioi; Makoto Hirota; Izumi Koike; Masaharu Hata; Iwai Tohnai

OBJECTIVES To evaluate the therapeutic results and rate of organ preservation in patients with squamous cell carcinoma of the tongue treated with retrograde superselective intra-arterial chemoradiotherapy. MATERIALS AND METHODS Between June 2006 and June 2015, 118 patients with tongue cancer were treated with intra-arterial chemoradiotherapy. Treatment consisted of radiotherapy (total 50-70 Gy) and daily concurrent intra-arterial chemotherapy (docetaxel, total 50-70 mg/m2; cisplatin, total 125-175 mg/m2) for 5-7 weeks. Locoregional control and overall survival rates were calculated by the Kaplan-Meier method. Coxs proportional hazards model was used for both univariate and multivariate analyses. RESULTS The median follow-up for all patients was 38.5 months (range, 3-129 months). After intra-arterial chemoradiotherapy, primary site complete response was achieved in 113 (95.8%) of 118 cases. Three-year locoregional control and overall survival rates were 80.3% and 81.5%, respectively. Grade 3 or 4 toxicities included neutropenia in 16.1% and mucositis in 87.3%. Grade 3 toxicities included anemia in 12.7%, thrombocytopenia in 3.4%, nausea/vomiting in 3.4%, dermatitis in 45.7%, dysphagia in 74.6%, and fever in 2.5% of patients. Late toxicity consisting of grade 3 osteoradionecrosis of the jaw occurred in 4.2% of patients. On univariate analysis, T stage and overall stage were significantly associated with locoregional control, and N stage and overall stage were significantly associated with overall survival. On multivariate analysis, the only significant predictor of overall survival was overall stage classification. CONCLUSION Retrograde superselective intra-arterial chemoradiotherapy for tongue cancer provided good overall survival and locoregional control.


Oncotarget | 2018

Treatment of oral cancer using magnetized paclitaxel

Rina Nakakaji; Masanari Umemura; Kenji Mitsudo; Jeong Hwan Kim; Yujiro Hoshino; Itaru Sato; Takatsugu Masuda; Masahiro Yamamoto; Mitomu Kioi; Toshiyuki Koizumi; Takayuki Fujita; Utako Yokoyama; Masaki Iida; Motohiko Sato; Hiroshi Sato; Shoko Murofushi; Sayaka Shibata; Ichio Aoki; Haruki Eguchi; Iwai Tohnai; Yoshihiro Ishikawa

N,N’-Bis(salicylidene)ethylenediamine iron (Fe(Salen)) is an anti-cancer agent with intrinsic magnetic property. Here, we covalently linked Fe(Salen) to paclitaxel (PTX), a widely used anti-cancer drug, to obtain a magnetized paclitaxel conjugate (M-PTX), which exhibited magnetic characteristics for magnet-guided drug delivery and MRI visualization. M-PTX increased apoptosis and G2/M arrest of cultured human oral cancer cell lines in the same manner as PTX. Furthermore, marked contrast intensity was obtained in magnetic resonance imaging (MRI) of M-PTX. In a mouse oral cancer model, a permanent magnet placed on the body surface adjacent to the tumor resulted in distinct accumulation of M-PTX, and the anti-cancer effect was greater than that of M-PTX without the magnet. We believe that this strategy may improve future cancer chemotherapy by providing conventional anti-cancer drugs with novel functionalities such as magnet-guided drug delivery or MRI-based visualization/quantitation of drug distribution.


POJ Dental and Oral Care | 2017

Implant Treatment for the Patients with Severe Deep Bite Using Screwed Denture: Technical Note

Noriaki Aoki; Arisa Inoue; Yasufumi Kosugi; Chika Koyama; Masaki Iida; Toshinori Iwai

Copyright:


POJ Dental and Oral Care | 2017

A Simple Self-Made Scale to Design Surgical Margin in Tongue Cancer: Technical Note

Noriaki Aoki; Arisa Inoue; Yasufumi Kosugi; Chika Koyama; Masaki Iida; Toshinori Iwai

Copyright:


Journal of Dentistry, Oral Disorders & Therapy | 2017

Pathological Fracture Successfully Treated with Simple Orthodontic Appliance, Chin Cup after Cyst Removal

Noriaki Aoki; Arisa Inoue; Yasufumi Kosugi; Chika Koyama; Masaki Iida; Toshinori Iwai; Iwai Tohnai

Dentigerous cysts are common odontogenic cysts associated with the crowns of unerupted teeth. Large dentigerous cysts rarely cause pathological fractures in the mandible. We describe the previously unreported treatment of pathological fracture derived from dentigerous cyst including an unerupted mandibular third molar, utilizing orthodontic appliance, chin cup as conservative therapy. This procedure can avoid the surgical open reduction and maxillomandibular fixation to reduce pathological fracture of mandible.


Radiation Oncology | 2017

Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old

Yuichiro Hayashi; Kenji Mitsudo; Kaname Sakuma; Masaki Iida; Toshinori Iwai; Hideyuki Nakashima; Yoshiyuki Okamoto; Toshiyuki Koizumi; Senri Oguri; Makoto Hirota; Mitomu Kioi; Izumi Koike; Masaharu Hata; Iwai Tohnai


Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2017

Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: Control of occult neck metastasis

Shuhei Minamiyama; Kenji Mitsudo; Yuichiro Hayashi; Masaki Iida; Toshinori Iwai; Hideyuki Nakashima; Senri Oguri; Tomomichi Ozawa; Toshiyuki Koizumi; Makoto Hirota; Mitomu Kioi; Iwai Tohnai

Collaboration


Dive into the Masaki Iida's collaboration.

Top Co-Authors

Avatar

Iwai Tohnai

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Toshinori Iwai

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Kenji Mitsudo

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mitomu Kioi

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Makoto Hirota

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Senri Oguri

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chika Koyama

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Masaharu Hata

Yokohama City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge